© 2009 American Public Health Association DOI: 10.2105/AJPH.2008.158170
James D. Heffelfinger, Pragna Patel, John T. Brooks, Hazel D. Dean, John Jereb, Charlotte K. Kent, Philip J. Peters, Lauretta Pinckney, Philip Spradling, Andrew C. Voetsch, and Anthony Fiore are with the Centers for Disease Control and Prevention (CDC), Atlanta, GA. Helene Calvet is with the Long Beach Department of Health and Human Services, Long Beach, CA. Charles L. Daley is with the National Jewish Medical and Research Center, Denver, CO. Brian R. Edlin is with the State University of New York Downstate Medical Center, Brooklyn, NY. Kathleen F. Gensheimer is with the Maine Department of Health and Human Services, Augusta, ME. Jeffrey L. Lennox is with Emory University, Atlanta. Janice K. Louie is with the California Department of Public Health, Berkeley, CA. Ruth Lynfield is with the Minnesota Department of Health, St. Paul, MN. Correspondence: Correspondence should be sent to James D. Heffelfinger, 1600 Clifton Road NE, Centers for Disease Control and Prevention, Mail Stop: E-46, Atlanta, GA 30333 (e-mail: izh7{at}cdc.gov). Reprints can be ordered at http://www.ajph.org by clicking on the "Eprints/Reprints" link.
Among vulnerable populations during an influenza pandemic are persons with or at risk for HIV infection, tuberculosis, or chronic viral hepatitis. HIV-infected persons have higher rates of hospitalization, prolonged illness, and increased mortality from influenza compared with the general population. Persons with tuberculosis and chronic viral hepatitis may also be at increased risk of morbidity and mortality from influenza because of altered immunity and chronic illness. These populations also face social and structural barriers that will be exacerbated by a pandemic. Existing infrastructure should be expanded and pandemic planning should include preparations to reduce the risks for these populations. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||